Exosomes: Novel Players of Therapy Resistance in Neuroblastoma.

Antibody-dependent cell cytotoxicity Chemotherapy Disialoganglioside Exosome biogenesis Exosomes Extracellular vesicles Immunotherapy MYCN Metastasis Multivesicular bodies Neuroblastoma Non-coding RNAs Pericytes Tumor microenvironment Tumor-associated monocytes

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 14 1 2021
Statut: ppublish

Résumé

Neuroblastoma is a solid tumor (a lump or mass), often found in the small glands on top of the kidneys, and most commonly affects infants and young children. Among neuroblastomas, high-risk neuroblastomas are very aggressive and resistant to most kinds of intensive treatment. Immunotherapy, which uses the immune system to fight against cancer, has shown great promise in treating many types of cancer. However, high-risk neuroblastoma is often resistant to this approach as well. Recent studies revealed that small vesicles known as exosomes, which are envelopes, could deliver a cargo of small RNA molecules and provide communication between neuroblastoma cells and the surrounding cells and trigger metastasis and resistance to immunotherapy. In this chapter, we describe the role of exosomes and small RNA molecules in the metastasis and regression of neuroblastoma and the potential therapeutic approaches to combat this menace.

Identifiants

pubmed: 33119866
doi: 10.1007/978-3-030-50224-9_5
pmc: PMC7775408
mid: NIHMS1656255
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-85

Subventions

Organisme : NCI NIH HHS
ID : K22 CA197074
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA036727
Pays : United States

Références

N Engl J Med. 2010 Sep 30;363(14):1313-23
pubmed: 20879880
Front Cell Dev Biol. 2018 Feb 20;6:18
pubmed: 29515996
J Clin Oncol. 2015 Sep 20;33(27):3008-17
pubmed: 26304901
Semin Cancer Biol. 2011 Oct;21(4):229-37
pubmed: 21971567
J Clin Oncol. 2005 Sep 20;23(27):6459-65
pubmed: 16116153
Am Soc Clin Oncol Educ Book. 2016;35:e548-57
pubmed: 27249766
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30
pubmed: 19713447
J Neurosurg. 2015 Apr;122(4):856-67
pubmed: 25594326
Trends Cell Biol. 2017 Mar;27(3):172-188
pubmed: 27979573
Cell Biosci. 2019 Feb 15;9:19
pubmed: 30815248
Mol Oncol. 2020 Jan;14(1):180-196
pubmed: 31637848
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
J Natl Cancer Inst. 2015 May 13;107(7):
pubmed: 25972604
Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C25-38
pubmed: 24788248
J Clin Oncol. 2009 Jan 10;27(2):289-97
pubmed: 19047291
Nat Rev Drug Discov. 2006 Mar;5(3):219-34
pubmed: 16518375
Circulation. 2012 Nov 27;126(22):2601-11
pubmed: 23114789
In Vivo. 2014 Jul-Aug;28(4):425-34
pubmed: 24982206
Front Oncol. 2019 Jun 12;9:459
pubmed: 31249805
Stem Cell Res. 2010 May;4(3):214-22
pubmed: 20138817
J Extracell Vesicles. 2017 Jun 25;6(1):1332941
pubmed: 28717423
Adv Pediatr. 2011;58(1):297-311
pubmed: 21736987
Front Cardiovasc Med. 2017 Oct 09;4:63
pubmed: 29062835
J Extracell Vesicles. 2019 Apr 11;8(1):1597614
pubmed: 31007876
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Bioessays. 2014 Jun;36(6):617-26
pubmed: 24737341
Stem Cell Res Ther. 2013 Apr 25;4(2):39
pubmed: 23680102
Neural Regen Res. 2015 Oct;10(10):1565-7
pubmed: 26692841
J Natl Cancer Inst. 1999 Aug 18;91(16):1382-90
pubmed: 10451443
Exp Ther Med. 2016 Apr;11(4):1519-1525
pubmed: 27073476
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Stem Cells. 2012 Jul;30(7):1556-64
pubmed: 22605481
Blood. 1999 Dec 1;94(11):3791-9
pubmed: 10572093
Stem Cell Res. 2013 May;10(3):301-12
pubmed: 23399448
Cancer Res. 2019 Mar 15;79(6):1151-1164
pubmed: 30541743
Pediatr Clin North Am. 2008 Feb;55(1):97-120, x
pubmed: 18242317
N Engl J Med. 2010 Sep 30;363(14):1324-34
pubmed: 20879881
Proteomics. 2017 Dec;17(23-24):
pubmed: 28722341
Curr Biol. 2012 Feb 21;22(4):R116-20
pubmed: 22361144
N Engl J Med. 2010 Jun 10;362(23):2202-11
pubmed: 20558371
Traffic. 2011 Dec;12(12):1659-68
pubmed: 21645191

Auteurs

Heather Richard (H)

High School Alliance Health Sciences Enrichment Program, Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Arya Pokhrel (A)

High School Alliance Health Sciences Enrichment Program, Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Srinivas Chava (S)

Department of Biochemistry and Molecular Biology & The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

Anup Pathania (A)

Department of Biochemistry and Molecular Biology & The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

Santharam S Katta (SS)

REVA University, Rukmini Knowledge Park Kattigenahalli, Yelahanka, Bangalore, Karnataka, India.

Kishore B Challagundla (KB)

Department of Biochemistry and Molecular Biology & The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. kishore.challagundla@unmc.edu.
The Children's Health Research Institute, University of Nebraska Medical Center, Omaha, NE, USA. kishore.challagundla@unmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH